These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 36882454)

  • 41. Guillain-Barré syndrome after COVID-19 vaccination.
    McKean N; Chircop C
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34330729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature.
    Min YG; Ju W; Ha YE; Ban JJ; Lee SA; Sung JJ; Shin JY
    J Neuroimmunol; 2021 Oct; 359():577691. PubMed ID: 34416410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Guillain-Barre syndrome and thrombocytopenia after SARS-CoV-2 vaccination with Moderna. A case report].
    Lázaro C; Llauradó A; Sánchez-Tejerina D; Cabirta A; Carpio C; Sotoca J; Salvadó M; Raguer N; Restrepo J; Juntas R
    Rev Neurol; 2022 Oct; 75(8):247-250. PubMed ID: 36218255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination.
    Allen CM; Ramsamy S; Tarr AW; Tighe PJ; Irving WL; Tanasescu R; Evans JR
    Ann Neurol; 2021 Aug; 90(2):315-318. PubMed ID: 34114269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Guillain-Barre syndrome before and during the COVID-19 pandemic in a referral center of Mexico.
    López-Hernández JC; Vargas-Cañas ES; Estrada SA; Galnares-Olalde J
    Gac Med Mex; 2023; 159(4):315-321. PubMed ID: 37699231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARS-CoV-2 Vaccination and Neuroimmunological Disease: A Review.
    Willison AG; Pawlitzki M; Lunn MP; Willison HJ; Hartung HP; Meuth SG
    JAMA Neurol; 2024 Feb; 81(2):179-186. PubMed ID: 38227318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post coronavirus disease-2019 vaccination Guillain-Barré syndrome.
    Biswas A; Pandey SK; Kumar D; Vardhan H
    Indian J Public Health; 2021; 65(4):422-424. PubMed ID: 34975092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Guillain-Barré Syndrome in Mexico: An Updated Review Amid the Coronavirus Disease 2019 ERA.
    Galnares-Olalde JA; López-Hernández JC; García-Grimshaw M; Valdés-Ferrer SI; Briseño-Godínez ME; de-Sarachaga AJ; Alegría-Loyola MA; Bazán-Rodriguez A; Martínez-Jiménez E; Vargas-Cañas ES
    Rev Invest Clin; 2022 May; 74(3):121-130. PubMed ID: 35345064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.
    Abuawwad MT; Taha MJJ; Taha AJ; Kozaa YA; Falah O; Abuawwad IT; Hammad EM; Mahmoud AA; Aladawi M; Serhan HA
    Clin Neurol Neurosurg; 2024 Mar; 238():108183. PubMed ID: 38401232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surveillance for Guillain-Barré syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season.
    Perez-Vilar S; Wernecke M; Arya D; Lo AC; Lufkin B; Hu M; Chu S; MaCurdy TE; Kelman J; Forshee RA
    Vaccine; 2019 Jun; 37(29):3856-3865. PubMed ID: 31122853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism.
    Malekpour M; Khanmohammadi S; Meybodi MJE; Shekouh D; Rahmanian MR; Kardeh S; Azarpira N
    Immun Inflamm Dis; 2023 May; 11(5):e875. PubMed ID: 37249286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS.
    Bellucci M; Germano F; Grisanti S; Castellano C; Tazza F; Mobilia EM; Visigalli D; Novi G; Massa F; Rossi S; Durando P; Cabona C; Schenone A; Franciotta D; Benedetti L
    Front Immunol; 2022; 13():894872. PubMed ID: 35924236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans.
    Wise ME; Viray M; Sejvar JJ; Lewis P; Baughman AL; Connor W; Danila R; Giambrone GP; Hale C; Hogan BC; Meek JI; Murphree R; Oh JY; Reingold A; Tellman N; Conner SM; Singleton JA; Lu PJ; DeStefano F; Fridkin SK; Vellozzi C; Morgan OW
    Am J Epidemiol; 2012 Jun; 175(11):1110-9. PubMed ID: 22582209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Guillain Barre syndrome associated with coronavac vaccine. Report of one case].
    Wimmer Del-Solar J; Chávez-Martel P; Fontecilla-Villalobos E; Ibáñez-Rodríguez P; Rozas-Vidal JP
    Rev Med Chil; 2022 Jan; 150(1):125-130. PubMed ID: 35856975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up.
    Ahmad L; Businaro P; Regalbuto S; Gastaldi M; Zardini E; Panzeri M; Vegezzi E; Fiamingo G; Colombo E; Ravaglia S
    Medicine (Baltimore); 2022 Jul; 101(30):e29704. PubMed ID: 35905215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
    Kim C; Rhie S; Suh M; Kang DR; Choi YJ; Bae GR; Choi YC; Jun BY; Lee JS
    Vaccine; 2015 Apr; 33(15):1815-23. PubMed ID: 25728315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome.
    Keddie S; Pakpoor J; Mousele C; Pipis M; Machado PM; Foster M; Record CJ; Keh RYS; Fehmi J; Paterson RW; Bharambe V; Clayton LM; Allen C; Price O; Wall J; Kiss-Csenki A; Rathnasabapathi DP; Geraldes R; Yermakova T; King-Robson J; Zosmer M; Rajakulendran S; Sumaria S; Farmer SF; Nortley R; Marshall CR; Newman EJ; Nirmalananthan N; Kumar G; Pinto AA; Holt J; Lavin TM; Brennan KM; Zandi MS; Jayaseelan DL; Pritchard J; Hadden RDM; Manji H; Willison HJ; Rinaldi S; Carr AS; Lunn MP
    Brain; 2021 Mar; 144(2):682-693. PubMed ID: 33313649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Post COVID-19 vaccination Guillain-Barre syndrome: three cases.
    Tabatabaee S; Rezania F; Alwedaie SMJ; Malekdar E; Badi Z; Tabatabaei SM; Mirzaasgari Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2045153. PubMed ID: 35240922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report.
    Rossetti A; Gheihman G; O'Hare M; Kosowsky JM
    J Emerg Med; 2021 Dec; 61(6):e141-e145. PubMed ID: 34538679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.